共 50 条
Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma
被引:21
作者:
Wang Xiao-Xue
[1
]
Huang Xinyue
[1
]
Zhang Lijun
[1
]
机构:
[1] China Med Univ, Hosp 1, Dept Hematol, Shenyang 110001, Peoples R China
来源:
MEDICINA CLINICA
|
2020年
/
154卷
/
02期
基金:
中国国家自然科学基金;
关键词:
Lymphoma;
PET-CT;
SUVmax;
Bone marrow infiltration;
Ann Arbor stage;
B-CELL LYMPHOMA;
F-18-FDG PET/CT;
MALIGNANT-LYMPHOMA;
HODGKIN-LYMPHOMA;
BIOPSY;
INVOLVEMENT;
CT;
DISEASE;
D O I:
10.1016/j.medcli.2019.07.022
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: Positron emission tomography-computed tomography (PET-CT) and bone marrow biopsy are currently the common clinical examination of lymphoma infiltration. The aim of this research is to evaluate the value of PET-CT in diagnosis of bone marrow infiltration, clinical staging and pathological typing of lymphoma. Methods: 153 cases were analyzed retrospectively to compare the consistency of PET-CT and bone marrow biopsy. We analyzed the sensitivity, accuracy and specificity of PET-CT in different clinical pathology of lymphoma. Results: The PET-CT sensitivity in detecting bone marrow infiltration is 54.3% with a specificity of 80.5% and accuracy of 74.5%. In aggressive B-cell lymphoma (DLBCL, HG-BL) and MZL, PET-CT results of bone marrow infiltration showed high accuracy of 88.1% and 83.3% respectively. The median value of SUVmax in the patients detected to have bone marrow infiltration by BMB was significantly higher than patients with BMB negative results among subgroups of aggressive B-cell lymphoma, MZL and T-NHL (p<.05). Conclusion: PET-CT is significant in detecting bone marrow infiltration in certain pathological types of lymphoma. However pathological inconsistencies still exist between bone marrow biopsy and PET-CT, thus PET-CT cannot completely replace biopsy. (C) 2019 The Authors. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 50 条